NewAmsterdam Pharma今日宣布,其关键性3期临床研究BROADWAY中的一项预设阿尔茨海默病(AD)生物标志物分析取得积极顶线结果。BROADWAY试验的主要目标是评估其口服、选择性胆固醇酯转运蛋白(CETP)抑制剂obicetrapib降低动脉粥样硬化性心血管疾病(ASCVD)和/或杂合型家族性高胆固醇血症(HeFH)成人
$0.01 per share on stocks & ETF trades, $0.75 option contracts ($1 for 1st contract), and no extra charge for broker assisted trades. Open an account today and get a cash bonus up to $1,000*. Plus, access to 150 markets across 34 countries and the Zacks Rank Trading Tool. Open An...
Last, M1 Finance does not charge commissions, account opening fees or management fees, but you will still be charged the ETF expense ratios (outside of M1’s control). Note that M1 only allows to trade once a day as a way to keep low costs, so it is not designed for day traders. ...
10 of the Best REITs to Buy for 2025 REITs are a great way to add real estate to your investment portfolio. Wayne DugganApril 8, 2025 Investing 6 Best Tech Stocks of the Past Decade These tech stocks have crushed their competition and outperformed their peers, much to the delight of long...
Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 UROGEN PHARMA LTD. -25.79% UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement BRADY CORPORATION -6.19% Brady Corporation Declares Regular Dividend to Shareholders, Payable on ...
As of 06/05/2025. In order to capture or receive a dividend, investors must own a stock, ETF or mutual fund before a certain date. This is called the ex-dividend date. Holding a stock-...View more Filter by Security Type StocksETFsActive ETFsFunds ...
FundPicker makes mutual fund selection super-convenient. With more than 50 filters, an advanced super-fast mutual fund screener and different views, mutual fund selection is now a cake walk.
Amneal Pharma Recalls USP 400 Mg/80 Mg Sulfamethoxazole/Trimethoprim Tablets 1 hour ago • RTTNews Markets Scotts Miracle-Gro Reiterates Annual Outlook 1 hour ago • RTTNews Markets ETF Fundamental Report for XLF 1 hour ago • Validea Markets ETF Fundamental Report for XLE 1 hour ag...
$46.35 billion. Prominent names in XPH’s fold includeJohnson & Johnson(NYSE:JNJ) andPfizer Inc.(NYSE:PFE), but this healthcare ETF also features some mid-cap names that could be legitimate takeover targets. For the investors that prefer, large-cap pharma names, there is good news as ...
stocks dividends data etfs top rated etfs etf strategies reits & real estate etfs commodity etfs emerging markets etfs growth vs. value etfs bonds country etfs education podcasts videos investing groups portfolios find & compare stock screener all stocks top rated stocks top growth stocks top value ...